Incremental dosage of the new antipsychotic mazapertine induces tolerance to cardiovascular and cognitive effects in healthy men*-Reference-Cited by-同舟云学术

Incremental dosage of the new antipsychotic mazapertine induces tolerance to cardiovascular and cognitive effects in healthy men*

Published:1996-06 Issue:6 Volume:59 Page:675-685
ISSN:0009-9236
Container-title:Clinical Pharmacology & Therapeutics
language:
Short-container-title:Clin Pharmacol Ther

Author:

Kleinbloesem Cornelis H.,Jaquet-Müller Françoise,Al-Hamdan Yousif,Baldauf Cornelia,Gisclon Lee,Wesnes Keith,Curtin Christopher R.,John Stubbs R.,Walker Sally A.,Brunner-Ferber Françoise

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology

Reference18 articles.

1. Clinically relevant differences between antipsychotic compounds

2. Developments in the drug treatment of schizophrenia

3. Antipsychotic drug doses and neuroleptic/dopamine receptors

4. Selective D1- and D2-dopamine receptor blockade both induces akathisia in humans — a PET study with [11C]SCH 23390 and [11C]raclopride

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bridging and CSF Studies;Critical Pathways to Success in CNS Drug Development;2010-03-05

2. An automated system for assessing cognitive function in any environment;SPIE Proceedings;2005-05-23

3. Reboxetine versus paroxetine versus placebo: effects on cognitive functioning in depressed patients;International Clinical Psychopharmacology;2003-01

4. Biomarkers for the effects of antipsychotic drugs in healthy volunteers;British Journal of Clinical Pharmacology;2001-02

5. Current and Novel Approaches to the Drug Treatment of Schizophrenia;Journal of Medicinal Chemistry;2001-02-01